Lista de obras - Paul M. Coplan - Dominio Público Uruguay

A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA, Merck) in children and adults

artículo científico publicado en 2004

A retrospective cohort study of long-term immediate-release hydrocodone/acetaminophen use and acetaminophen dosing above the Food and Drug Administration recommended maximum daily limit among commercially insured individuals in the United States (20

artículo científico publicado en 2015

Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment

artículo científico publicado en 2012

Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review.

artículo científico publicado en 2016

Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform

scientific article published on 20 April 2020

Application of the BRAT Framework to Case Studies: Observations and Insights

artículo científico publicado en 2010

Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records

artículo científico publicado en 2017

Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist

artículo científico

Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics.

artículo científico publicado en 2013

Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System.

artículo científico publicado en 2016

Controlling controlled substances abuse and misuse by managed care payers: a new generation of risk management initiatives?

artículo científico

Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon.

artículo científico publicado en 2006

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents

artículo científico publicado en 2005

Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin).

artículo científico publicado en 2016

Development of a framework for enhancing the transparency, reproducibility and communication of the benefit-risk balance of medicines

artículo científico publicado en 2010

Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory

article

Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system data.

artículo científico publicado en 2016

Impact of an intervention to improve treatment-seeking behavior and prevent sexually transmitted diseases among Nigerian youths

artículo científico publicado en 2003

Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine

artículo científico publicado en 2004

Impact of vaccination on the epidemiology of varicella: 1995-2009.

artículo científico publicado en 2014

Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease

artículo científico publicado en 2001

Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors.

artículo científico publicado en 2003

Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: an analysis of three randomized clinical trials

artículo científico publicado en 2003

Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials

artículo científico publicado en 2001

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

article

Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study

artículo científico publicado en 2013

Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

article

Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse

artículo científico publicado en 2014

Pharmacokinetic Assessment of Dapivirine Vaginal Microbicide Gel in Healthy, HIV-Negative Women

article

Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men.

artículo científico publicado en 2003

Post-marketing evaluation of the short term safety of COMVAX.

artículo científico publicado en 2004

Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania

artículo científico publicado en 2007

Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties

artículo científico publicado en 2016

Public health. Regulatory challenges in microbicide development

artículo científico publicado en 2004

Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010.

artículo científico publicado en 2013

Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation

artículo científico publicado en 2014

Risk factors of HIV-1 infection among female prostitutes in Khon Kaen, Northeast Thailand

artículo científico publicado el 1 de noviembre de 1992

Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring

artículo científico publicado en 2009

Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women

artículo científico publicado en 2009

The Selective Toxicity of Medications Used in the Treatment of Aids on the Cem Human Leukemic CD4+ T-Cell Line ⬇️

artículo científico publicado el 1 de enero de 1991

The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.

artículo científico publicado en 2016

The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers

artículo científico publicado en 2014

The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults

artículo científico publicado en 2007

The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics ⬇️

artículo científico publicado en 2008

The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania

artículo científico publicado en 2007

Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis

artículo científico publicado en 2016

Lista de obras de Paul M. Coplan

A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA, Merck) in children and adults

A retrospective cohort study of long-term immediate-release hydrocodone/acetaminophen use and acetaminophen dosing above the Food and Drug Administration recommended maximum daily limit among commercially insured individuals in the United States (20

Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment

Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review.

Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform

Application of the BRAT Framework to Case Studies: Observations and Insights

Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records

Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist

Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics.

Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System.

Controlling controlled substances abuse and misuse by managed care payers: a new generation of risk management initiatives?

Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon.

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents

Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin).

Development of a framework for enhancing the transparency, reproducibility and communication of the benefit-risk balance of medicines

Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory

Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system data.

Impact of an intervention to improve treatment-seeking behavior and prevent sexually transmitted diseases among Nigerian youths

Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine

Impact of vaccination on the epidemiology of varicella: 1995-2009.

Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease

Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors.

Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: an analysis of three randomized clinical trials

Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study

Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse

Pharmacokinetic Assessment of Dapivirine Vaginal Microbicide Gel in Healthy, HIV-Negative Women

Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men.

Post-marketing evaluation of the short term safety of COMVAX.

Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania

Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties

Public health. Regulatory challenges in microbicide development

Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010.

Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation

Risk factors of HIV-1 infection among female prostitutes in Khon Kaen, Northeast Thailand

Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring

Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women

The Selective Toxicity of Medications Used in the Treatment of Aids on the Cem Human Leukemic CD4+ T-Cell Line ⬇️

The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.

The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers

The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults

The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics ⬇️

The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania

Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis